// App-Quantinova.ai

3231 : Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes effector function

Researchers

Presenter

  • Jerome Giustiniani

Principal Investigators

  • Adele de Masson

  • Anne Marie-Cardine

  • Jean-David Bouaziz

  • Christian Garbar

  • Martine Bagot

  • Yacine Merrouche

  • Armand Bensussan

Medical Centers

  • Institut Jean Godinot/Unicancer, Reims, France

  • Harvard Skin Disease Research Center, Boston, MA

  • INSERM U , Universite Paris VII Paris Diderot, Paris, France

  • INSERM U , Service de Dermatologie, Hopital Saint-Louis, Paris, France

  • INSERM U , Service de Dermatologie, Hopital Saint-Louis, Paris, France

Locations

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Myosin Heavy Chain 8

  • Natural Killer cells

  • Surfactant Protein A

Drug/Treatment

  • Trastuzumab

  • Erbitux

  • Rituximab

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved